Fig. 2From: Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunitiesTME targeting strategies to treat B-cell lymphoma. MDSC, TAM (M2), TAN (N2) and Treg inhibit the process of the antitumor immune response through several inhibition pathways and establish an immunosuppressive TMEBack to article page